![Atreca Inc](/common/images/company/N_BCEL.png)
CAMPBELL, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (βAtrecaβ) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery...
SAN CARLOS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | -0.159 | -51.4563106796 | 0.309 | 0.394 | 0.15 | 3163695 | 0.27979154 | CS |
52 | -0.83 | -84.693877551 | 0.98 | 1.15 | 0.1023 | 3953301 | 0.28585224 | CS |
156 | -7.9 | -98.1366459627 | 8.05 | 8.8156 | 0.1023 | 1370812 | 1.27623766 | CS |
260 | -16.31 | -99.0886998785 | 16.46 | 29.35 | 0.1023 | 886865 | 2.83182049 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.